Grant H. Skrepnek, Ph.D., R.Ph.

Associate Professor

Department of Pharmacy: Clinical and Administrative Sciences

Phone (405) 271-6878 x47105

Fax (4050 271-6430

Office CPB 214

Email grant-skrepnek@ouhsc.edu


Summary

I concentrate on health economics, policy, and outcomes research involving large-scale database investigations, decision analyses, clinical trials, and survey research. From a clinical stance, I focus on studying cost, quality, and access to care across various healthcare settings concerning oncology, cardiopulmonary disease, rare conditions, and comorbidities. I am engaged in advancing the methodological approaches used within assessments of health technology, including the development of novel statistical procedures to evaluate health and economic data.



Research

Dr. Skrepnek concentrates on health economics, policy, and outcomes research involving large-scale database investigations, decision analyses, clinical trials, and survey research. From a clinical stance, Dr. Skrepnek focuses on studying cost, quality, and access to care across various healthcare settings concerning oncology, cardiopulmonary disease, rare conditions, and comorbidities. He is engaged in advancing the methodological approaches used within assessments of health technology, including the development of novel statistical procedures to evaluate health and economic data.




Education & Experience

Ph.D. in Pharmacy Administration

University of Texas at Austin, Austin, TX

Dissertation: Stock market valuation and firm-level determinants of innovative activity in the pharmaceutical industry.


2002

M.S. in Pharmacy Administration

University of Texas at Austin, Austin, TX

Thesis: The effect of merger and acquisition activity on shareholder returns in the pharmaceutical industry.


1998

B.S. in Pharmacy Business Management

University of Texas at Austin, Austin, TX

1994


Publications & Presentations

1 2 3 4 > >>
  • Gilligan A, Alberts D, Roe D, Skrepnek G H. The Financial Toxicity of Cancer Among the Newly-Diagnosed. American Journal of Medicine. 2018
  • Fox A, Skrepnek G H, Miller J L, Schwier N C, Ripley T L. Optimal Medical Therapy Prescribing Patterns and Disparities Identified in Patients with Acute Coronary Syndromes at an Academic Medical Center in an Area with High Coronary Heart Disease-Related Mortality. American journal of cardiovascular drugs : drugs, devices, and other interventions. 2018
  • Miller J L, Ernst K, Neely S, Stephens K, Parker P, Skrepnek G H, Johnson P N. Low-dose versus high-dose methadone for the management of neonatal abstinence syndrome. Journal of Opioid Management. In Press
  • McMorris T E, Smith W J, Kupiec K, Salvaggio M, Skrepnek G H, Abraham L, Resendez S. Micafungin Therapy for Symptomatic Candiduria in Hospitalized Patients. Infectious Diseases in Clinical Practice. 2017; 25 : 88-93
  • Combs D, Skrepnek G H, Seckeler M D, Barber B J, Morgan W J, Parthasarathy S. Sleep-disordered breathing is associated with increased mortality in hospitalized infants with congenital heart disease. Journal of Clinical Sleep Medicine. In Press
  • 1 2 3 4 > >>